title: Reversal of the adverse cardiovascular effects of intravenous diltiazem in anesthetized dogs.
abstract: Intravenous diltiazem can be used to treat myocardial ischemia, hypertension, and supraventricular dysrhythmias, but significant adverse effects including atrioventricular block and hypotension have been reported. At the present time, there is controversy as to which drug is most effective in reversing these sequelae. This study was designed to assess the effectiveness of calcium chloride v epinephrine in reversing these side effects. The hemodynamic and electrophysiologic effects of diltiazem infusion were investigated in eight dogs anesthetized with fentanyl and nitrous oxide/oxygen. This study confirmed that diltiazem infusions in high concentrations produced predominantly atrioventricular conduction depression followed by profound hypotension. Epinephrine infusion proved to be most effective in attenuating and eliminating each of these deleterious side effects. In contrast, calcium chloride did not significantly increase heart rate or blood pressure or reverse atrioventricular block. In two instances calcium chloride produced further depression of atrioventricular conduction, leading to severe bradycardia and sinus arrest. Although calcium chloride increased left ventricular contractile force (LV dP/ dt) and cardiac index (CI), mean arterial pressure was not affected and SVR was further decreased. This study indicates that calcium chloride should not be given to reverse the side effects of diltiazem in the presence of atrioventricular conduction block or profound hypotension. Calcium chloride is indicated only when isolated myocardial depression is present and after the calcium channels have been reopened by epinephrine.
authors.affiliation: Departments of Anesthesiology and the Division of Cardiothoracic Surgery, Mount Sinai School of Medicine (CUNY), New York, NY 10029, USA.
authors.forename: I
authors.initials: I
authors.lastname: Dimich
authors.forename: J
authors.initials: J
authors.lastname: Profeta
authors.forename: R
authors.initials: R
authors.lastname: Jurado
authors.forename: H
authors.initials: H
authors.lastname: Chiang
authors.forename: J A
authors.initials: JA
authors.lastname: Kaplan
mesh_terms: D000758:Anesthesia; D000818:Animals; D001283:Atrioventricular Node / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000633:toxicity*; D002122:Calcium Chloride / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D004110:Diltiazem / Q000097:blood / Q000633:toxicity*; D004285:Dogs; D004562:Electrocardiography / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D007275:Injections, Intravenous; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D002121:Calcium Channel Blockers; D004110:Diltiazem; D002122:Calcium Chloride; D004837:Epinephrine